Physician profile
Daniel R Gerry
NPI 1639406598
$2,434.44
in general payments reported to CMS, 2019-2025
21 companies · $646 in 2025
The $646 reported for 2025 was more than what 77% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $759 · 2021: $492 · 2022: $62.43 · 2023: $98.47 · 2024: $177 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $920.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $891.58 | 2020-2025 | Inspire |
| Stryker Corporation | $474.04 | 2021-2022 | |
| Aerin Medical INC. | $290.21 | 2024-2025 | |
| Genzyme Corporation | $267.16 | 2019-2025 | |
| Glaxosmithkline, LLC. | $65.29 | 2023-2025 | Nucala |
| Janssen Biotech, INC. | $60.95 | 2019-2021 | |
| Abbvie INC. | $60.18 | 2019 | |
| Optinose US, INC. | $54.04 | 2020-2021 | |
| Leo Pharma INC. | $40.98 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $37.72 | 2025 | Dupixent |
| Mayne Pharma Commercial LLC | $27.05 | 2019 | |
| Medtronic, INC. | $21.16 | 2023 | Propel |
| Acclarent, INC | $20.12 | 2021 | |
| Acera Surgical, INC. | $19.92 | 2025 | Restrata Wound Matrix |
| Acelrx Pharmaceuticals, INC. | $18.46 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $18.20 | 2019 | |
| Intersect Ent, INC. | $17.10 | 2020 | |
| Hikma Pharmaceuticals USA | $14.70 | 2025 | Ryaltris |
| Epi Health, LLC | $14.51 | 2019 | |
| Laborie Medical Technologies Corp. | $13.23 | 2025 | |
| Forte Bio-Pharma LLC | $7.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gerry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.